CAR T-cell therapy for relapsed or refractory multiple myeloma
- PMID: 31085047
- DOI: 10.1016/S1470-2045(19)30288-8
CAR T-cell therapy for relapsed or refractory multiple myeloma
Comment on
-
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma.N Engl J Med. 2019 May 2;380(18):1726-1737. doi: 10.1056/NEJMoa1817226. N Engl J Med. 2019. PMID: 31042825 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical